Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe

Frank A Post; Daniel Grint; Anne Marie Werlinrud Efsen; Alexander Panteleev; Vieja Riekstina; Evgeniy A Malashenkov; Alena Skrahina; Dan Duiculescu; Daria Podlekareva; Igor Karpov; Vasiliy Bondarenko; Nelly Chentsova; Jens Lundgren; Amanda Mocroft; Ole Kirk; Jose M Miro; HIV-TB Study Group

doi:10.1016/j.jinf.2013.09.034

Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe

Frank A Post, Daniel Grint, Anne Marie Werlinrud Efsen, Alexander Panteleev, Vieja Riekstina, Evgeniy A Malashenkov, Alena Skrahina, Dan Duiculescu, Daria Podlekareva, Igor Karpov, Vasiliy Bondarenko, Nelly Chentsova, Jens Lundgren, Amanda Mocroft, Ole Kirk, Jose M Miro, HIV-TB Study Group

Department of Clinical Medicine

29 Citations (Scopus)

Abstract

Observational data from Eastern Europe on the management and outcome of multi-drug-resistant tuberculosis (MDR TB) in HIV positive populations remain sparse in the English-language literature.We compared clinical characteristics and outcomes of 55 patients who were diagnosed with HIV and MDR TB in Eastern Europe between 2004 and 2006 to 89 patients whose Mycobacterium tuberculosis isolates were susceptible to isoniazid and rifampicin.Patients with HIV and MDR TB were young and predominantly male with high rates of intravenous drug use, imprisonment and hepatitis C co-infection. Eighty-four per cent of patients with MDR TB had no history of previous TB drug exposure suggesting that the majority of MDR TB resulted from transmission of drug-resistant M. tuberculosis. The use of non-standardized tuberculosis treatment was common, and the use of antiretroviral therapy infrequent. Compared to those with susceptible tuberculosis, patients with MDR TB were less likely to achieve cure or complete tuberculosis treatment (21.8% vs. 62.9%, p

Original language	English
Journal	Journal of Infection
Volume	68
Issue number	3
Pages (from-to)	259-263
Number of pages	5
ISSN	0163-4453
DOIs	https://doi.org/10.1016/j.jinf.2013.09.034
Publication status	Published - Mar 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jinf.2013.09.034

Cite this

Post, F. A., Grint, D., Efsen, A. M. W., Panteleev, A., Riekstina, V., Malashenkov, E. A., Skrahina, A., Duiculescu, D., Podlekareva, D., Karpov, I., Bondarenko, V., Chentsova, N., Lundgren, J., Mocroft, A., Kirk, O., Miro, J. M., & HIV-TB Study Group (2014). Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe. Journal of Infection, 68(3), 259-263. https://doi.org/10.1016/j.jinf.2013.09.034

Post, FA, Grint, D, Efsen, AMW, Panteleev, A, Riekstina, V, Malashenkov, EA, Skrahina, A, Duiculescu, D, Podlekareva, D, Karpov, I, Bondarenko, V, Chentsova, N, Lundgren, J, Mocroft, A, Kirk, O, Miro, JM & HIV-TB Study Group 2014, 'Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe', Journal of Infection, vol. 68, no. 3, pp. 259-263. https://doi.org/10.1016/j.jinf.2013.09.034

@article{b69b42f1a4e846e8a8ff73a25db75577,

title = "Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe",

abstract = "Observational data from Eastern Europe on the management and outcome of multi-drug-resistant tuberculosis (MDR TB) in HIV positive populations remain sparse in the English-language literature.We compared clinical characteristics and outcomes of 55 patients who were diagnosed with HIV and MDR TB in Eastern Europe between 2004 and 2006 to 89 patients whose Mycobacterium tuberculosis isolates were susceptible to isoniazid and rifampicin.Patients with HIV and MDR TB were young and predominantly male with high rates of intravenous drug use, imprisonment and hepatitis C co-infection. Eighty-four per cent of patients with MDR TB had no history of previous TB drug exposure suggesting that the majority of MDR TB resulted from transmission of drug-resistant M. tuberculosis. The use of non-standardized tuberculosis treatment was common, and the use of antiretroviral therapy infrequent. Compared to those with susceptible tuberculosis, patients with MDR TB were less likely to achieve cure or complete tuberculosis treatment (21.8% vs. 62.9%, p",

author = "Post, {Frank A} and Daniel Grint and Efsen, {Anne Marie Werlinrud} and Alexander Panteleev and Vieja Riekstina and Malashenkov, {Evgeniy A} and Alena Skrahina and Dan Duiculescu and Daria Podlekareva and Igor Karpov and Vasiliy Bondarenko and Nelly Chentsova and Jens Lundgren and Amanda Mocroft and Ole Kirk and Miro, {Jose M} and {HIV-TB Study Group}",

year = "2014",

month = mar,

doi = "10.1016/j.jinf.2013.09.034",

language = "English",

volume = "68",

pages = "259--263",

journal = "Journal of Infection",

issn = "0163-4453",

publisher = "W.B.Saunders Co. Ltd.",

number = "3",

}

TY - JOUR

T1 - Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe

AU - Post, Frank A

AU - Grint, Daniel

AU - Efsen, Anne Marie Werlinrud

AU - Panteleev, Alexander

AU - Riekstina, Vieja

AU - Malashenkov, Evgeniy A

AU - Skrahina, Alena

AU - Duiculescu, Dan

AU - Podlekareva, Daria

AU - Karpov, Igor

AU - Bondarenko, Vasiliy

AU - Chentsova, Nelly

AU - Lundgren, Jens

AU - Mocroft, Amanda

AU - Kirk, Ole

AU - Miro, Jose M

AU - HIV-TB Study Group

PY - 2014/3

Y1 - 2014/3

N2 - Observational data from Eastern Europe on the management and outcome of multi-drug-resistant tuberculosis (MDR TB) in HIV positive populations remain sparse in the English-language literature.We compared clinical characteristics and outcomes of 55 patients who were diagnosed with HIV and MDR TB in Eastern Europe between 2004 and 2006 to 89 patients whose Mycobacterium tuberculosis isolates were susceptible to isoniazid and rifampicin.Patients with HIV and MDR TB were young and predominantly male with high rates of intravenous drug use, imprisonment and hepatitis C co-infection. Eighty-four per cent of patients with MDR TB had no history of previous TB drug exposure suggesting that the majority of MDR TB resulted from transmission of drug-resistant M. tuberculosis. The use of non-standardized tuberculosis treatment was common, and the use of antiretroviral therapy infrequent. Compared to those with susceptible tuberculosis, patients with MDR TB were less likely to achieve cure or complete tuberculosis treatment (21.8% vs. 62.9%, p

AB - Observational data from Eastern Europe on the management and outcome of multi-drug-resistant tuberculosis (MDR TB) in HIV positive populations remain sparse in the English-language literature.We compared clinical characteristics and outcomes of 55 patients who were diagnosed with HIV and MDR TB in Eastern Europe between 2004 and 2006 to 89 patients whose Mycobacterium tuberculosis isolates were susceptible to isoniazid and rifampicin.Patients with HIV and MDR TB were young and predominantly male with high rates of intravenous drug use, imprisonment and hepatitis C co-infection. Eighty-four per cent of patients with MDR TB had no history of previous TB drug exposure suggesting that the majority of MDR TB resulted from transmission of drug-resistant M. tuberculosis. The use of non-standardized tuberculosis treatment was common, and the use of antiretroviral therapy infrequent. Compared to those with susceptible tuberculosis, patients with MDR TB were less likely to achieve cure or complete tuberculosis treatment (21.8% vs. 62.9%, p

UR - http://www.scopus.com/inward/record.url?scp=84894062806&partnerID=8YFLogxK

U2 - 10.1016/j.jinf.2013.09.034

DO - 10.1016/j.jinf.2013.09.034

M3 - Journal article

C2 - 24247067

AN - SCOPUS:84894062806

SN - 0163-4453

VL - 68

SP - 259

EP - 263

JO - Journal of Infection

JF - Journal of Infection

IS - 3

ER -

Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this